PLAAT4
Phospholipase A and acyltransferase 4
Also known as: HRASLS4, PLAAT-4, PLAT4_HUMAN, RARRES3, RIG1, TIG3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UL19
- Gene
- PLAAT4
- Ensembl
- ENSG00000133321
- Chromosome
- 11
- Canonical length
- 164 aa
- Protein class
- Enzymes, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene. RARRES3 is thought act as a tumor suppressor or growth regulator. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
164 residues, UniProt reviewed canonical sequence.
>Q9UL19|PLAAT4
1 MASPHQEPKP GDLIEIFRLG YEHWALYIGD GYVIHLAPPS EYPGAGSSSV FSVLSNSAEV
61 KRERLEDVVG GCCYRVNNSL DHEYQPRPVE VIISSAKEMV GQKMKYSIVS RNCEHFVTQL
121 RYGKSRCKQV EKAKVEVGVA TALGILVVAG CSFAIRRYQK KATALocalizationUniProt · AlphaFold · HPA
Whether an antibody against PLAAT4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 190 nTPM
Expression across tissuesHPA
Tissue
- kidney: 190 nTPM
- lung: 104 nTPM
- liver: 101 nTPM
- breast: 96 nTPM
- small intestine: 96 nTPM
- fallopian tube: 93 nTPM
Single-cell type
- enterocytes: 532 nCPM
- epididymal clear cells: 414 nCPM
- salivary ionocytes: 358 nCPM
- alveolar cells type 1: 345 nCPM
- epididymal efferent duct ciliated cells: 298 nCPM
- respiratory secretory cells: 272 nCPM
Immune cell
- total PBMC: 563 nTPM
- memory CD8 T-cell: 454 nTPM
- gdT-cell: 428 nTPM
- naive CD8 T-cell: 372 nTPM
- MAIT T-cell: 329 nTPM
- memory CD4 T-cell: 325 nTPM
Brain region
- medulla oblongata: 57 nTPM
- hypothalamus: 41 nTPM
- white matter: 38 nTPM
- thalamus: 33 nTPM
- pons: 30 nTPM
- amygdala: 27 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.92
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- lipid catabolic process
- N-acylphosphatidylethanolamine metabolic process
- negative regulation of cell population proliferation
- phosphatidylethanolamine acyl-chain remodeling
- phospholipid metabolic process
- positive regulation of keratinocyte differentiation
- positive regulation of protein-glutamine gamma-glutamyltransferase activity
Molecular functions
- acyltransferase activity
- N-acyltransferase activity
- phospholipase A1 activity
- phospholipase A2 activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PLAAT4 as an antibody target. Whether an autoantibody or antibody against PLAAT4 could matter depends on whether native PLAAT4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PLAAT4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PLAAT4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...